NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Yes it is. All of my research and due diligence points to NWBO being significantly undervalued, and a very good investment. I was fortunate enough to accumulate a lot of NWBO shares at $0.16, $0.18, $0.21, $0.23, etc.

I continually update my research every week to confirm and re-confirm my NWBO investment thesis.

The interim DCVax-L blinded and blended ITT results were very positive. I am very optimistic and encouraged as long as I continue to see positive DCVax-L feedback, views and expectations from Key Opinion Leaders (KOLs) like: Dr. Linda Liau, Dr. Ashkan Keyoumars, Dr. Robert Prins, Dr. Timothy Cloughesy, Dr. Steven Brem, Dr. John Trusheim, etc.

I have to compare their collective backgrounds, knowledge and experience as esteemed neurosurgeons, neuro-oncologists, researchers and scientists, against the NWBio shorts and detractors.